Marshall Wace’s NeueHealth NEUE Stock Holding History

Marshall Wace’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,715	Closed	-$1.85M	–	4131
2021 Q4	$1.85M	Buy	6,715 +5,237	+354%	+$2.42M	﹤0.01%	2090
2021 Q3	$965K	Buy	+1,478	New	+$1.3M	﹤0.01%	2044

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

MCAV

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Marshall Wace's NEUE Position: Q1 2022 in Review

Marshall Wace sold out of NeueHealth (NEUE) in Q1 2022, closing a stake of 6,715 shares — an estimated $1.85M sold.

Marshall Wace first reported a position in NEUE in Q3 2021 and held it in 2 quarters. The position peaked at $1.85M in Q4 2021. 121 funds tracked by Wall St. Rank hold NEUE as of Q1 2022.

Marshall Wace reported no remaining NeueHealth position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 6,715 NeueHealth shares in Q1 2022, an estimated $1.85M.
Marshall Wace first reported a position in NeueHealth in Q3 2021 and held it in 2 quarters.
Marshall Wace's NeueHealth position peaked at $1.85M in Q4 2021.
121 funds tracked by Wall St. Rank held NeueHealth as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.